NEW YORK, New York – (August XX, 2023): With the pharmaceutical industry set to expand to $1.1B by the end of this year, Mitchell Ashley, founder of New York City’s Ashley Law Firm, provides valuable insights on pharmaceutical litigation. When a medication results in unwanted and unexpected side effects that cause a user harm, consumers are not without options when it comes to pursuing compensation. The key is knowing how to identify a violation of personal rights – and where to turn with that information.
Earlier this year, several major news outlets covered an emerging phenomenon of “facial aging” caused by certain weight loss medications. In situations like these, it is often difficult for one user to prove a direct link between the medication in question and the symptoms they experience. For this reason, pharmaceutical litigation typically involves either a class action lawsuit, in which one representative client sues on behalf of a larger group, or a mass tort lawsuit, in which each plaintiff is represented individually.
“Our practice mostly manages mass tort litigation, which I feel provides my clients with the best possible outcome to their cases,” shares Ashley, a seasoned personal injury attorney of more than 20 years. “I’m happy to refer class action clients to any number of qualified outside firms, and I often stay on as a local advocate and advisor for these individuals without adding extra financial cost to the process.”
